[1] 王亮春,卜定方,杨勇,等.伴发Castleman瘤的副肿瘤性天疱疮发病机制研究中华皮肤科杂志,2004,37:38-40.
[2] Yamada M, Hudson S, Tournay O, et al. Detection of minimal disease in hematopoietic malignancies of the B-call lineage by using third-complementarity-determining region (CDR-Ⅲ)-specific probes. Proc Natl Acad Sci U S A, 1989, 86:5123-5127.
[3] Liu AY, Valenzuela R, Helm TN, et al. Indirect immunofluorescence on rat bladder transitional epithelium:a test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol, 1993,28:696-699.
[4] Helou J, Allbritton J, Anhalt GJ. Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol, 1995, 32:441-447.
[5] Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus.An autoimmune mucocutaneous disease associated with neoplasia.N Engl J Med, 1990, 323:1729-1735.
[6] Hashimoto T, Amagai M, Watanabe K, et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol, 1995, 104:829-834.
[7] Kim SC, Kwon YD, Lee IJ, et al. cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex. J Invest Dermatol, 1997, 109:365-369.
[8] Mimouni D, Anhalt GJ, Lazarova Z,et al. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol, 2002, 147:725-732.
[9] Joly P, Richard C, Gilbert D, et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol, 2000, 43:619-626. |